Daily dose evaluation based on corrected CBCTs for breast cancer patients: accuracy of dose and complication risk assessment.

MLA

Hamming, Vincent C., et al. “Daily Dose Evaluation Based on Corrected CBCTs for Breast Cancer Patients: Accuracy of Dose and Complication Risk Assessment.” Radiation Oncology, vol. 17, no. 1, Dec. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13014-022-02174-4.

APA

Hamming, V. C., Andersson, S., Maduro, J. H., Langendijk, J. A., Both, S., & Sijtsema, N. M. (2022). Daily dose evaluation based on corrected CBCTs for breast cancer patients: accuracy of dose and complication risk assessment. Radiation Oncology, 17(1), 1–11. https://doi.org/10.1186/s13014-022-02174-4

Chicago

Hamming, Vincent C., Sebastian Andersson, John H. Maduro, Johannes A. Langendijk, Stefan Both, and Nanna M. Sijtsema. 2022. “Daily Dose Evaluation Based on Corrected CBCTs for Breast Cancer Patients: Accuracy of Dose and Complication Risk Assessment.” Radiation Oncology 17 (1): 1–11. doi:10.1186/s13014-022-02174-4.